Walk the supplement aisle of any pet retailer and the marketing converges on one ingredient. Fish oil sits on the front of the bottle, attached to a large milligram figure and a promise about coat or mobility. The figure that describes what the product actually delivers, how much EPA is in a serving, appears far less often. That raises a commercial question for brands and retailers: what does a label need to show to support a premium price?
Fish Oil Is Not the Same as EPA
Omega-3 is a family of fatty acids rather than a single compound. EPA (eicosapentaenoic acid) and DHA come from marine sources such as sardines, anchovies, and salmon, and dogs absorb them directly. ALA comes from plant oils including flaxseed and chia, and dogs convert it into EPA and DHA inefficiently.
The distinction matters commercially because “1,000 mg of fish oil” and “300 mg of EPA” describe different things. Fish oil is a source of EPA and DHA, but the total fish-oil amount does not tell a shopper how much of either fatty acid the product provides.
Where Labeled and Measured Amounts Diverge
A 2025 study in Topics in Companion Animal Medicine, from researchers at the University of California, Davis, analyzed selected nutrients and contaminants in fish oil supplements sold for pets, comparing product contents against label claims.
Measured EPA and DHA concentrations varied considerably between products, and varied against label claims in both directions. Most labels carried a minimum content claim for the two fatty acids, and some products did not meet those claims when analyzed. Label accuracy was better in the 2021 samples than in the 2010 samples, although some claims were still not met.
The difficulty is not that supplements are untrustworthy. It is that a minimum claim is hard for anyone outside the company to evaluate.
Where the Comparison Breaks Down
A dog parent learning about EPA omega-3 benefits before choosing a supplement gets little from a guaranteed analysis that lists only total fish oil. There is no reliable way for a shopper to determine the daily EPA amount from that figure alone.
Solving that is where the commercial opportunity sits. Clear disclosure gives brands an opportunity to demonstrate formulation quality rather than asking dog parents to infer it from marketing language alone.
Why the Specific Dose Matters
A 2025 review in Nutrition Research Reviews, from a team at the University of São Paulo, examined omega-3 supplementation studies in dogs and cats with chronic conditions, standardising doses where possible. The authors concluded that the EPA and DHA doses they reviewed appear effective for several conditions, while noting insufficient evidence for others.
The operative word is doses. That evidence base rests on specific quantities of EPA and DHA, not on the presence of fish oil as an ingredient. A product delivering a substantially different dose should not automatically be assumed to provide the same effects observed in studies using specific EPA and DHA amounts. Dosing for an individual dog belongs with a veterinarian, since body weight and health status both factor in.
What Greater Transparency Can Look Like
There is no single mandated format, and the right combination depends on formulation and intended use. Examples of information a brand can make available:
- EPA and DHA stated separately in milligrams per serving, not folded into one combined omega-3 figure
- A clear basis for the serving size, including body weight where the product’s intended use makes that relevant
- A certificate of analysis for the specific production lot, available on request
- Third-party testing that evaluates relevant measures such as potency and oxidation
- A named marine source in place of a generic fish oil declaration
Ingredient-level education sits alongside this, giving a household something concrete to check a label against. Disclosure here is largely voluntary, and the pattern is familiar across industries: voluntary disclosure can become a competitive differentiator before it becomes an expected standard.
Final Thoughts
As the pet wellness category has adopted many of the positioning strategies familiar from human supplements, expectations around transparency have risen with them. EPA content is where that shows up most plainly, because it reduces to a single figure that is either printed on the panel or not. For operators, the question is not whether to talk about omega-3s. It is whether the label holds up when read closely.
Article received via email
